Potassium Ion

Potassium Ion

SCHEMBL380009

C=C1[C@H]2CC[C@H]3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@H]1O.[K+].[K+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 1.00
HPSE Q9Y251 14/20 0.32
FGF1 P05230 9/20 0.32
FGF2 P09038 8/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL30190052 1.00 MAPT (1.00) MAPTHPSEFGF1FGF2
Potassium Ion SCHEMBL28493998 1.00 MAPT (1.00) MAPTHPSEFGF1FGF2
Potassium Ion SCHEMBL29767873 1.00 MAPT (1.00) MAPTHPSEFGF1FGF2
Water SCHEMBL6357796 0.99 MAPT (0.99) MAPTHPSEFGF1FGF2
SCHEMBL3765566 0.94 MAPT (0.89) MAPTHPSE
SCHEMBL20456989 0.94 MAPT (0.89) MAPTHPSE
SCHEMBL21046219 0.94 MAPT (0.89) MAPTHPSE
SCHEMBL15634985 0.94 MAPT (0.88) MAPTHPSE
SCHEMBL25014383 0.87 MAPT (0.78) MAPT
SCHEMBL19255997 0.87 MAPT (0.78) MAPTHPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504901-A Coffee atractyloside with hypoglycemic activity, and preparation method and application thereof 中国科学院昆明植物研究所 2025-02-25 CN claimed
CN-115639297-B Fingerprint construction, identification and detection method of fructus xanthil and fried fructus xanthil traditional Chinese medicine formula particles 广东一方制药有限公司 2024-08-16 CN claimed
CN-114199818-B Construction method of near infrared quantitative detection model of fructus xanthil traditional Chinese medicine formula particles and quantitative detection method thereof 广东一方制药有限公司 2024-05-14 CN claimed
CN-114469967-B Application of atractyloside A and derivatives thereof in preparation of anxiolytic and antidepressant drugs 江西中医药大学 2024-02-20 CN claimed
US-11819535-B2 Composition and methods for regulating extracellular matrix accumulation UNIVERSITY HEALTH NETWORK (CA) 2023-11-21 US claimed
CN-115184491-B Method for measuring chemical component content in qing Jin Yi gas granule 天津中医药大学 2023-08-01 CN claimed
CN-115639297-A Fingerprint construction, identification and detection method of fructus xanthil and fried fructus xanthil traditional Chinese medicine formula particles 广东一方制药有限公司 2023-01-24 CN claimed
CN-114624349-B Method for analyzing traditional Chinese medicinal materials in lung-heat clearing and toxin expelling decoction formula 中国科学院大连化学物理研究所 2022-12-27 CN claimed
CN-115364144-A Yuqing lobular Kuding tea extract and preparation method and application thereof 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2022-11-22 CN claimed
CN-115184491-A Method for measuring chemical component content in Qingjin Yiqi granules 天津中医药大学 2022-10-14 CN claimed
WO-2000026370-A9 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2001-11-15 WO claimed
EP-1116027-A1 IDENTIFYING AGENTS THAT ALTER MITOCHONDRIAL PERMEABILITY TRANSITION PORES MITOKOR (US) 2001-07-18 EP claimed
WO-2001032876-A2 COMPOSITIONS AND METHODS FOR DETERMINING INTERACTIONS OF MITOCHONDRIAL COMPONENTS, AND FOR IDENTIFYING AGENTS THAT ALTER SUCH INTERACTIONS MITOKOR (US) 2001-05-10 WO claimed
WO-2001016373-A2 ASSAYING OF MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSLOCATION MITOKOR (US) 2001-03-08 WO claimed
WO-2000079274-A2 METHODS FOR ASSAYING SUBCELLULAR CONDITIONS USING ENERGY TRANSFER MITOKOR (US) 2000-12-28 WO claimed
EP-1049780-A1 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2000-11-08 EP claimed
WO-2000019200-A9 IDENTIFYING AGENTS THAT ALTER MITOCHONDRIAL PERMEABILITY TRANSITION PORES MITOKOR (US) 2000-08-31 WO claimed
WO-2000026370-A2 ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF MITOKOR (US) 2000-05-11 WO claimed
WO-2000019200-A1 IDENTIFYING AGENTS THAT ALTER MITOCHONDRIAL PERMEABILITY TRANSITION PORES MITOKOR (US) 2000-04-06 WO claimed
WO-1999006588-A1 A CELL-FREE SYSTEM OF MITOCHONDRIA-DEPENDENT APOPTOSIS, AND METHODS OF USE THEREOF THE BURNHAM INSTITUTE (US) 1999-02-11 WO claimed